Skip to main content

Iron Deficiency

Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency
NCT02937454 | PHASE 4 | INTERVENTIONAL

Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency (Affirm-AHF)

Trial Information
16 Sites
1132 Participants
COMPLETED
18 Years

If interested, contact clinicaltrials@cslbehring.com or +1 610-878-4697 for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

Hospital Universitario Austral
Buenos Aires,Argentina,1500
InCor Instituto do Corao HCFMUSP
São Paulo,Brazil,05403-900
Clinical Hospital Center Rijeka
Rijeka,Croatia,05403-900
Aleksandre Aladashvili Clinic LLC
Tbilisi,Georgia,0102
The Baruch Pade Medical Center
Tiberias,Lower Galilee,Israel,15208
Hadassah Ein Kerem University Medical Center
Jerusalem,Lower Galilee,Israel,91120
Spedali Civilia di Brescia
Brescia,Lower Galilee,Italy,91120
American University of Beirut Medical Center
Beirut,Lower Galilee,Lebanon,1107-2020
Vasculair Onderzoek Centrum
Hoorn,Lower Galilee,Netherlands,1107-2020
Clinical Military Hospital
Wroclaw,Lower Galilee,Poland,50-891
Emergency Clinical Hospital
Bucharest,Lower Galilee,Romania,014461
National Heart Centre of Singapore Pte
Singapore,Lower Galilee,Singapore,169609
University of Murcia
Murcia,Lower Galilee,Spain,30001
Skane University Hospital
Malmö,Lower Galilee,Sweden,SE20502
The M.D. Strazhesko Institute of Cardiology
Kyiv,Lower Galilee,Ukraine,02000
Kings College Hospital NHS Foundation
London,Lower Galilee,United Kingdom,02000

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov